Suzhou MedicalSystem Technology Co., Ltd. (SHA:603990)
China · Delayed Price · Currency is CNY 15.18
+0.01 (0.07%)
Apr 16, 2026, 3:00 PM CST
SHA:603990 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 300.4 | 461.39 | 616.95 | 304.25 | 352.11 |
Other Revenue | 1.08 | 2.68 | 1.19 | 1.25 | 1.74 |
| 301.48 | 464.07 | 618.14 | 305.51 | 353.85 | |
Revenue Growth (YoY) | -35.04% | -24.93% | 102.33% | -13.66% | 14.86% |
Cost of Revenue | 119.5 | 412.9 | 505.32 | 90.05 | 106.86 |
Gross Profit | 181.98 | 51.17 | 112.82 | 215.46 | 246.99 |
Selling, General & Admin | 137.46 | 227.7 | 271.5 | 122.93 | 147.19 |
Research & Development | 28.6 | 51.18 | 50.04 | 47.41 | 48 |
Other Operating Expenses | -6.09 | -6.2 | -6.19 | -9.57 | -12.79 |
Operating Expenses | 164.69 | 265.72 | 331.73 | 182.16 | 203.16 |
Operating Income | 17.29 | -214.55 | -218.91 | 33.3 | 43.83 |
Interest Expense | -12.89 | -71.81 | -48.3 | -3.97 | -6.69 |
Interest & Investment Income | 31.16 | 3.7 | 11.92 | 10.09 | 8.76 |
Currency Exchange Gain (Loss) | 0 | -0.01 | 0.11 | - | -0 |
Other Non Operating Income (Expenses) | -0.14 | -18.64 | -0.42 | 0.29 | 0.74 |
EBT Excluding Unusual Items | 35.42 | -301.31 | -255.6 | 39.71 | 46.64 |
Gain (Loss) on Sale of Investments | 0.1 | -0.44 | -2.32 | 0.07 | 1.14 |
Gain (Loss) on Sale of Assets | 0.16 | -0.21 | -0.03 | -0.06 | 0.09 |
Asset Writedown | 9.77 | -45.2 | -0.02 | -0 | -0.05 |
Other Unusual Items | -0.05 | 93.42 | -4.01 | 3.84 | 3.51 |
Pretax Income | 45.4 | -253.73 | -261.99 | 43.56 | 51.34 |
Income Tax Expense | 3.91 | 23.87 | 3.25 | 8.07 | 7.83 |
Earnings From Continuing Operations | 41.49 | -277.6 | -265.24 | 35.49 | 43.5 |
Minority Interest in Earnings | -2.33 | -1.88 | -4.18 | -1.93 | -1.55 |
Net Income | 39.16 | -279.47 | -269.42 | 33.56 | 41.95 |
Net Income to Common | 39.16 | -279.47 | -269.42 | 33.56 | 41.95 |
Net Income Growth | - | - | - | -20.00% | 18.37% |
Shares Outstanding (Basic) | 301 | 304 | 306 | 280 | 273 |
Shares Outstanding (Diluted) | 301 | 304 | 306 | 280 | 273 |
Shares Change (YoY) | -0.84% | -0.78% | 9.47% | 2.53% | 9.29% |
EPS (Basic) | 0.13 | -0.92 | -0.88 | 0.12 | 0.15 |
EPS (Diluted) | 0.13 | -0.92 | -0.88 | 0.12 | 0.15 |
EPS Growth | - | - | - | -21.98% | 8.31% |
Free Cash Flow | -3.17 | -263.69 | -916.49 | 25.93 | -4.95 |
Free Cash Flow Per Share | -0.01 | -0.87 | -2.99 | 0.09 | -0.02 |
Gross Margin | 60.36% | 11.03% | 18.25% | 70.52% | 69.80% |
Operating Margin | 5.73% | -46.23% | -35.41% | 10.90% | 12.39% |
Profit Margin | 12.99% | -60.22% | -43.59% | 10.98% | 11.86% |
Free Cash Flow Margin | -1.05% | -56.82% | -148.27% | 8.49% | -1.40% |
EBITDA | 31.96 | -157.99 | -192.76 | 47.41 | 57.36 |
EBITDA Margin | 10.60% | -34.04% | -31.18% | 15.52% | 16.21% |
D&A For EBITDA | 14.67 | 56.55 | 26.16 | 14.12 | 13.53 |
EBIT | 17.29 | -214.55 | -218.91 | 33.3 | 43.83 |
EBIT Margin | 5.73% | -46.23% | -35.41% | 10.90% | 12.39% |
Effective Tax Rate | 8.61% | - | - | 18.52% | 15.25% |
Revenue as Reported | 301.48 | 464.07 | 618.14 | 305.51 | 353.85 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.